INVESTIGADORES
PIRIZ Joaquin
artículos
Título:
Serum insulin-like growth factor I and ischemic brain injury
Autor/es:
ENDRES M, PIRIZ J, GERTZ K, HARMS C, MEISEL A, KRONENBERG G, TORRES-ALEMAN I
Revista:
BRAIN RESEARCH
Editorial:
Elseiver
Referencias:
Lugar: Amsterdam; Año: 2007 vol. 1185 p. 328 - 335
ISSN:
0006-8993
Resumen:
Serum insulin-like growth factor I (IGF-I), which is mostly produced by the liver, has recently been shown to have the unexpected ability to modulate normal brain function as well as brain response to injury. Moreover, serum IGF-I levels are modified in many brain diseases, including stroke. However, whether these modifications are related to the disease process remains uncertain. We now examined a potential relationship between serum IGF-I and ischemic brain injury after middle cerebral artery occlusion (MCAo) and reperfusion in mice with either high or low serum IGF-I levels prior to insult. Surprisingly, we found that chronic high serum IGF-I correlates with increased brain infarct size following MCAo, while low levels correlate with reduced lesion size. Immunocytochemistry and immunoblot analyses revealed that levels of phosphorylated (i.e., activated) MAPK, known to be associated with the severity of ischemic brain injury, were increased in IGF-I treated mice. No overall effect of IGF-I treatment on IGF family mRNA expression in the brain was observed. Altogether, these results indicate that serum IGF-I levels negatively correlate with stroke outcome. Therefore, lowering serum IGF-I levels in aging mammals, including humans, may be beneficial against the increased risk of stroke associated to old age.